MyCartis NV:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MyCartis NV - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10366
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MyCartis NV (MyCartis), formerly Pronota NV, is an immuno-diagnostic solution provider. The company offers Evalution, a multiplex analysis platform that designs and develops protein and nucleic acid based biomarkers; and provides opportunity for researchers and assay developers to build multiplex assays for their biomarkers and measure them. It enables the combined analysis of protein and nucleic-acid biomarkers simultaneously and is intended for research use. MyCartis offers novel solutions in the fields of clinical and translational research. The company also develops research kits in the therapeutic areas of cardiovascular disease, oncology, and preeclampsia. MyCartis is headquartered in Zwijnaarde, Belgium.

MyCartis NV – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MyCartis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MyCartis NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MyCartis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MyCartis NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MyCartis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MyCartis NV, Medical Equipment, Deal Details 10
Venture Financing 10
MyCartis Raises USD19.4 Million in Venture Financing 10
Pronota Raises US$4.8 Million In Series C Financing 11
Partnerships 13
Biocartis Forms Joint Venture with Pronota 13
MyCartis NV – Key Competitors 14
MyCartis NV – Key Employees 15
MyCartis NV – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MyCartis NV, Medical Equipment, Key Facts 2
MyCartis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MyCartis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MyCartis NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MyCartis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MyCartis NV, Deals By Market, 2012 to YTD 2018 8
MyCartis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MyCartis Raises USD19.4 Million in Venture Financing 10
Pronota Raises US$4.8 Million In Series C Financing 11
Biocartis Forms Joint Venture with Pronota 13
MyCartis NV, Key Competitors 14
MyCartis NV, Key Employees 15

List of Figures
MyCartis NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MyCartis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MyCartis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MyCartis NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MyCartis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MyCartis NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MyCartis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MyCartis NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MyCartis NV:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Physio-Control Inc-医療機器分野:企業M&A・提携分析
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Bain Capital LLC is a medical device company that offers development, manufacturing, sale and service of emergency medical response products. The company provides pre-hospital, hospital, military, and accessory and disposable products. Its …
  • Microsemi Corporation (MSCC):企業の財務・戦略的SWOT分析
    Microsemi Corporation (MSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Millicom International Cellular SA (MIC SDB):企業の財務・戦略的SWOT分析
    Millicom International Cellular SA (MIC SDB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報
    Summary ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious disease …
  • Medherant Ltd:企業の製品パイプライン分析
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Iron Mountain Inc (IRM):企業の財務・戦略的SWOT分析
    Iron Mountain Inc (IRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Xantrex LLC:企業の戦略的SWOT分析
    Xantrex LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aeroport Anapa:企業の戦略・SWOT・財務分析
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hertz Global Holdings Inc:戦略・SWOT・企業財務分析
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sol-Gel Technologies Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a developer and manufacturer of topical dermatological drug products. The company’s products include Cool Pearls anti acne kit which is a benzoyl peroxide-based acne regime at commercial stage; and SGT-VD-54 is a non-antibiotic topical drug for the treat …
  • Evotec AG (EVT)-医療機器分野:企業M&A・提携分析
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Black Hills Corporation (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Bank of Panhsin:企業の戦略・SWOT・財務情報
    Bank of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-医療機器分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆